CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy | Zendy

AI Assistant Blog Pricing

CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.